Vial Logo
Back to Resources

White Paper: Looking Ahead: Gastroenterology Clinical Trial Landscape in 2023

Investigating the gastroenterology clinical trial landscape for 2021.

White Paper: Looking Ahead: Gastroenterology Clinical Trial Landscape in 2023

To meet the health needs of patients, the global GI drugs market is projected to grow at a compound annual growth rate (CAGR) of 6% from US$48.74 billion in 2021 to reach US$62.19 billion in 2025. Based on this, the market is valued at approximately US$54.8 billion in 2023. In 2020, North America held 48% of the global GI drugs market[3]. To bring new therapies to market, biopharma companies engage CROs for fast execution of high-quality clinical trials by leveraging their expertise in navigating the complex landscape of drug development and regulatory pathways.

This white paper will cover:

  • Growth in demand for gastroenterology CRO Services
  • Gastrointestinal Research Trends
  • Challenges and opportunities in GI trials: research waste, sex and gender bias, AI, and more
Get the Whitepaper

More Resources

Explore gene therapies for ophthalmic disorders like achromatopsia, age-related macular degeneration, and retinitis pigmentosa.

The Positive Impact of Gene Therapies to Treat Ophthalmologic Diseases

The evolving landscape of immuno-oncology.

The State of Immuno-Oncology

Vial's Technology drives efficient trials through data review workflows.

White Paper: How Vial’s Technology Powers More Efficient Trials — Data Review Workflows In-Action

Connect with us.

Interested in receiving a proposal from Vial? Leave us a message and some of your contact info and we’ll be in touch with you shortly.

Name(Required)
By submitting, you are agreeing to our terms and privacy policy
This field is for validation purposes and should be left unchanged.

We’ll send
the white paper to your email address
Name(Required)

By entering your email, you agree to our Terms and Condition & Privacy Policy